Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Cardurion Pharmaceuticals, Inc.

Cardurion Pharmaceuticals Appoints Karen Lewis as Chief People Officer
From Cardurion Pharmaceuticals, Inc.
Via Business Wire
Cardurion Pharmaceuticals Appoints Charlotte Newman as Chief Business Officer
From Cardurion Pharmaceuticals, Inc.
Via Business Wire
Cardurion Pharmaceuticals Selected as an Endpoints 11 Most Promising Biotech Company
From Cardurion Pharmaceuticals, Inc.
Via Business Wire
Cardurion Pharmaceuticals Appoints Ron Renaud to Board of Directors
From Cardurion Pharmaceuticals, Inc.
Via Business Wire
Cardurion Pharmaceuticals Announces $260 Million Series B Financing to Advance Its Pipeline of Innovative Medicines for Cardiovascular Diseases
From Cardurion Pharmaceuticals, Inc.
Via Business Wire
Cardurion Pharmaceuticals Presents Positive Clinical Results from CARDINAL‑HF Phase 2a Clinical Trial of PDE9 Inhibitor in Patients With Heart Failure
From Cardurion Pharmaceuticals, Inc.
Via Business Wire
Cardurion Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
From Cardurion Pharmaceuticals, Inc.
Via Business Wire
Cardurion Pharmaceuticals to Provide Update on CaMKII Inhibitor Program at the American Heart Association’s Scientific Sessions 2023
From Cardurion Pharmaceuticals, Inc.
Via Business Wire
Cardurion Pharmaceuticals Welcomes Emma Reeve as Independent Board Director and Audit Chair
From Cardurion Pharmaceuticals, Inc.
Via Business Wire
Cardurion Pharmaceuticals Strengthens Leadership Team with Appointment of Elizabeth Radcliffe as Chief Financial Officer
From Cardurion Pharmaceuticals, Inc.
Via Business Wire
Cardurion Pharmaceuticals Announces Dosing of Patients in CARDINAL-HF, a Phase 2 Clinical Trial of its PDE9 inhibitor in Heart Failure
From Cardurion Pharmaceuticals, Inc.
Via Business Wire
Cardurion Pharmaceuticals Enhances Leadership Team with Appointment of Marcia Moore as Chief Operating Officer
From Cardurion Pharmaceuticals, Inc.
Via Business Wire
Cardurion Pharmaceuticals Announces Investment of up to $300 Million From Bain Capital
From Cardurion Pharmaceuticals, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.